Status:
COMPLETED
Kalifilcon A Toric Compared to Commercially Available Lenses
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Astigmatism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Approximately thirty contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study.
Detailed Description
Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion stud...
Eligibility Criteria
Inclusion
- Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have capacity to read, understand and provide written voluntary informed consent.
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
- Have no active ocular disease or allergic conjunctivitis.
- Not be using any topical ocular medications.
- Be willing and able to follow instructions.
- Have signed a statement of informed consent.
Exclusion
- Participating in a conflicting study in the opinion of the Investigator.
- Considered by the Investigator to not be a suitable candidate for participation
Key Trial Info
Start Date :
September 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06098937
Start Date
September 5 2023
End Date
September 27 2023
Last Update
December 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bausch & Lomb, Incorporated
Rochester, New York, United States, 14609